Article Details

Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation

Retrieved on: 2022-12-27 13:46:58

Tags for this article:

Click the tags to see associated articles and topics

Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation. View article details on hiswai:

Excerpt

Gemini Therapeutics shares were up 18% at $1.83 in premarket trading Tuesday after its merger target, Disc Medicine Inc., received orphan drug ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up